Ambitious Bio has raised $6.0M in seed funding to build what it describes as the largest human proteomics dataset in the Western Hemisphere. The company did not disclose its investors.
Proteomics - the large-scale study of proteins - has become a growing focus for drug developers and researchers looking to understand disease at the molecular level. Ambitious Bio's pitch rests on scale: assembling a dataset large enough to be useful across the hemisphere, a costly and time-intensive undertaking that the seed capital will help fund.
